[PERSON]
Drew Weissman
Featured in 4 tracked stories · first seen
Situations
mRNA technology and personalized cancer vaccine research
2 clusters · 53 sources · last updated
Latest: Moderna and Merck mRNA melanoma vaccine reduces recurrence risk by 42%
Recent medical research highlights significant progress in using messenger RNA (mRNA) technology to develop personalized cancer vaccines. These vaccines utilize a patient’s specific tumor mutations or neoantigens to trai
Advances and challenges in mRNA and immunotherapy trials
11 clusters · 25 sources · last updated
Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers
Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ